# A Randomized Double Blind Placebo Controlled Study of the Effect of Swallowed Beclomethasone Dipropionate on Inflammatory Markers in Adult Patients With Eosinophilic Esophagitis

> **NCT01016223** · PHASE1 · COMPLETED · sponsor: **Penn State University** · enrollment: 20 (estimated)

## Conditions studied

- Eosinophilic Esophagitis

## Interventions

- **DRUG:** Beclomethasone dipropionate
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01016223
- **Lead sponsor:** Penn State University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03
- **Primary completion:** 2012-07
- **Final completion:** 2012-10
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2012-11-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01016223

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01016223, "A Randomized Double Blind Placebo Controlled Study of the Effect of Swallowed Beclomethasone Dipropionate on Inflammatory Markers in Adult Patients With Eosinophilic Esophagitis". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01016223. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*